source
- Opinion: STAT+: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changer“In truth, I don’t anticipate prescribing patterns changing immediately,” cardiologist Vishal Khetpal writes of the new cholesterol drug Lipfendra.STAT · 7d ago↗ source
- STAT+: Federal health quality research grants worth $109 million ended earlyAt least 78 AHRQ grants worth $200 million have been affected by "non-award" notices; it's estimated those grants had $109.2 million in funding remaining.STAT · 7d ago↗ source
- STAT+: More workers hate their jobs, but keep them for the health insuranceA new survey reveals 24% of U.S. workers stay in unwanted jobs to keep health insurance. Experts call it 'job lock.'STAT · 7d ago